217 related articles for article (PubMed ID: 11931659)
41. Crystal structure of the anti-bacterial sulfonamide drug target dihydropteroate synthase.
Achari A; Somers DO; Champness JN; Bryant PK; Rosemond J; Stammers DK
Nat Struct Biol; 1997 Jun; 4(6):490-7. PubMed ID: 9187658
[TBL] [Abstract][Full Text] [Related]
42. Examination of intrinsic sulfonamide resistance in Bacillus anthracis: a novel assay for dihydropteroate synthase.
Valderas MW; Andi B; Barrow WW; Cook PF
Biochim Biophys Acta; 2008 May; 1780(5):848-53. PubMed ID: 18342015
[TBL] [Abstract][Full Text] [Related]
43. Bisubstrate inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase: Transition state analogs for high affinity binding.
Shi G; Shaw GX; Zhu F; Tarasov SG; Ji X
Bioorg Med Chem; 2021 Jan; 29():115847. PubMed ID: 33199204
[TBL] [Abstract][Full Text] [Related]
44. The hydroxymethyldihydropterin pyrophosphokinase domain of the multifunctional folic acid synthesis Fas protein of Pneumocystis carinii expressed as an independent enzyme in Escherichia coli: refolding and characterization of the recombinant enzyme.
Ballantine SP; Volpe F; Delves CJ
Protein Expr Purif; 1994 Aug; 5(4):371-8. PubMed ID: 7950384
[TBL] [Abstract][Full Text] [Related]
45. Dihydropteroate synthase from Streptococcus pneumoniae: characterization of substrate binding order and sulfonamide inhibition.
Vinnicombe HG; Derrick JP
Biochem Biophys Res Commun; 1999 May; 258(3):752-7. PubMed ID: 10329458
[TBL] [Abstract][Full Text] [Related]
46. Catalytic roles of arginine residues 82 and 92 of Escherichia coli 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase: site-directed mutagenesis and biochemical studies.
Li Y; Wu Y; Blaszczyk J; Ji X; Yan H
Biochemistry; 2003 Feb; 42(6):1581-8. PubMed ID: 12578371
[TBL] [Abstract][Full Text] [Related]
47. Hamiltonian replica exchange method study of Escherichia coli and Yersinia pestis HPPK.
Su L; Cukier RI
J Phys Chem B; 2009 Dec; 113(50):16197-208. PubMed ID: 19924845
[TBL] [Abstract][Full Text] [Related]
48. Characterization of a novel bifunctional dihydropteroate synthase/dihydropteroate reductase enzyme from Helicobacter pylori.
Levin I; Mevarech M; Palfey BA
J Bacteriol; 2007 Jun; 189(11):4062-9. PubMed ID: 17416665
[TBL] [Abstract][Full Text] [Related]
49. Exploring the chemical space around 8-mercaptoguanine as a route to new inhibitors of the folate biosynthesis enzyme HPPK.
Chhabra S; Barlow N; Dolezal O; Hattarki MK; Newman J; Peat TS; Graham B; Swarbrick JD
PLoS One; 2013; 8(4):e59535. PubMed ID: 23565155
[TBL] [Abstract][Full Text] [Related]
50. An alternative pathway for reduced folate biosynthesis in bacteria and halophilic archaea.
Levin I; Giladi M; Altman-Price N; Ortenberg R; Mevarech M
Mol Microbiol; 2004 Dec; 54(5):1307-18. PubMed ID: 15554970
[TBL] [Abstract][Full Text] [Related]
51. Hydroxymethyldihydropterin pyrophosphokinase from Plasmodium falciparum complements a folK-knockout mutant in E. coli when expressed as a separate polypeptide detached from dihydropteroate synthase.
Jönsson M; Swedberg G
Mol Biochem Parasitol; 2005 Mar; 140(1):123-5. PubMed ID: 15694494
[No Abstract] [Full Text] [Related]
52. Essential roles of a dynamic loop in the catalysis of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase.
Blaszczyk J; Li Y; Wu Y; Shi G; Ji X; Yan H
Biochemistry; 2004 Feb; 43(6):1469-77. PubMed ID: 14769023
[TBL] [Abstract][Full Text] [Related]
53. Molecular motions and conformational changes of HPPK.
Keskin O; Ji X; Blaszcyk J; Covell DG
Proteins; 2002 Nov; 49(2):191-205. PubMed ID: 12211000
[TBL] [Abstract][Full Text] [Related]
54. Elucidation of sulfadoxine resistance with structural models of the bifunctional Plasmodium falciparum dihydropterin pyrophosphokinase-dihydropteroate synthase.
de Beer TA; Louw AI; Joubert F
Bioorg Med Chem; 2006 Jul; 14(13):4433-43. PubMed ID: 16517168
[TBL] [Abstract][Full Text] [Related]
55. Bisubstrate analog inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase: new lead exhibits a distinct binding mode.
Shi G; Shaw G; Li Y; Wu Y; Yan H; Ji X
Bioorg Med Chem; 2012 Jul; 20(14):4303-9. PubMed ID: 22727779
[TBL] [Abstract][Full Text] [Related]
56. 2.0 A X-ray structure of the ternary complex of 7,8-dihydro-6-hydroxymethylpterinpyrophosphokinase from Escherichia coli with ATP and a substrate analogue.
Stammers DK; Achari A; Somers DO; Bryant PK; Rosemond J; Scott DL; Champness JN
FEBS Lett; 1999 Jul; 456(1):49-53. PubMed ID: 10452528
[TBL] [Abstract][Full Text] [Related]
57. Structure of S. aureus HPPK and the discovery of a new substrate site inhibitor.
Chhabra S; Dolezal O; Collins BM; Newman J; Simpson JS; Macreadie IG; Fernley R; Peat TS; Swarbrick JD
PLoS One; 2012; 7(1):e29444. PubMed ID: 22276115
[TBL] [Abstract][Full Text] [Related]
58. Mutagenesis of folylpolyglutamate synthetase indicates that dihydropteroate and tetrahydrofolate bind to the same site.
Sheng Y; Khanam N; Tsaksis Y; Shi XM; Lu QS; Bognar AL
Biochemistry; 2008 Feb; 47(8):2388-96. PubMed ID: 18232714
[TBL] [Abstract][Full Text] [Related]
59. Elucidation of the catalytic mechanism of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase using QM/MM calculations.
Jongkon N; Gleeson D; Gleeson MP
Org Biomol Chem; 2018 Aug; 16(34):6239-6249. PubMed ID: 30109337
[TBL] [Abstract][Full Text] [Related]
60. Pterin-sulfa conjugates as dihydropteroate synthase inhibitors and antibacterial agents.
Zhao Y; Shadrick WR; Wallace MJ; Wu Y; Griffith EC; Qi J; Yun MK; White SW; Lee RE
Bioorg Med Chem Lett; 2016 Aug; 26(16):3950-4. PubMed ID: 27423480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
